230 related articles for article (PubMed ID: 28111196)
1. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
3. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802).
Hasegawa T; Takaki H; Kodama H; Matsuo K; Yamanaka T; Nakatsuka A; Takao M; Gobara H; Hayashi S; Inaba Y; Yamakado K
J Vasc Interv Radiol; 2023 Jan; 34(1):31-37.e1. PubMed ID: 36209996
[TBL] [Abstract][Full Text] [Related]
5. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
[TBL] [Abstract][Full Text] [Related]
6. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications.
McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886
[TBL] [Abstract][Full Text] [Related]
8. Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.
Matsui Y; Hiraki T; Gobara H; Uka M; Masaoka Y; Tada A; Toyooka S; Mitsuhashi T; Mimura H; Kanazawa S
J Vasc Interv Radiol; 2012 Jun; 23(6):780-5. PubMed ID: 22513393
[TBL] [Abstract][Full Text] [Related]
9. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.
Yasui K; Kanazawa S; Sano Y; Fujiwara T; Kagawa S; Mimura H; Dendo S; Mukai T; Fujiwara H; Iguchi T; Hyodo T; Shimizu N; Tanaka N; Hiraki Y
Radiology; 2004 Jun; 231(3):850-7. PubMed ID: 15105453
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
[TBL] [Abstract][Full Text] [Related]
11. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.
Matsui Y; Hiraki T; Gobara H; Fujiwara H; Iguchi T; Shirakawa Y; Fujiwara T; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2014 Oct; 25(10):1566-72. PubMed ID: 25156828
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience.
de Baere T; Robinson JM; Rao P; Teriitehau C; Deschamps F
J Vasc Interv Radiol; 2011 Jun; 22(6):749-54. PubMed ID: 21616429
[TBL] [Abstract][Full Text] [Related]
14. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
[TBL] [Abstract][Full Text] [Related]
16. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
Hiraki T; Sakurai J; Tsuda T; Gobara H; Sano Y; Mukai T; Hase S; Iguchi T; Fujiwara H; Date H; Kanazawa S
Cancer; 2006 Dec; 107(12):2873-80. PubMed ID: 17096433
[TBL] [Abstract][Full Text] [Related]
18. Local Efficacy and Survival after Microwave Ablation of Lung Tumors: A Retrospective Study in 183 Patients.
Zheng A; Ye X; Yang X; Huang G; Gai Y
J Vasc Interv Radiol; 2016 Dec; 27(12):1806-1814. PubMed ID: 27789077
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
[TBL] [Abstract][Full Text] [Related]
20. CT volumetric assessment of pulmonary neoplasms after radiofrequency ablation: when to consider a second intervention?
Nour-Eldin NE; Naguib NN; Tawfik AM; Gruber-Rouh T; Zangos S; Vogl TJ
J Vasc Interv Radiol; 2014 Mar; 25(3):347-54. PubMed ID: 24581459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
